LEGEND BIOTECH
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LEGEND BIOTECH Trademark

Serial Number: 97446452 • Registration: 7283305

LEGEND BIOTECH is a trademark filed by Nanjing Legend Biotech Co., Ltd. on June 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Nanjing Legend Biotech Co., Ltd. (6 trademarks)

No. 6 Bldg. of Nanjing Life Science Town
NANJING CITY, JIANGSU 211100 , CN

Entity Type: 03

LEGEND BIOTECH USA INC. (5 trademarks)

2101 COTTONTAIL LANE
SOMERSET, NJ 08873

Entity Type: 03

Trademark Details

Filing Date

June 7, 2022

Registration Date

January 23, 2024

Published for Opposition

November 7, 2023

Goods & Services

Scientific and technological services, namely, scientific research, analysis, and testing in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposes, for others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposes, for others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming

Medical services; alternative medicine services; cultured cell bank services for medical transplantation; health care; health centre services; health counselling; health assessment services; hospital services; medical advice for individuals with disabilities; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical clinic services; medical treatment using cultured cells; preparation of prescriptions by pharmacists; therapy services, namely, immunotherapy, cell therapy, gene therapy, antibody therapy, radiation therapy, or chemotherapy; Medical services relating to the removal, treatment and processing of human cells; Providing cancer screening services; Medical services for the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for cancer diagnosis and prognosis; Medical screening; provision of medical information; stem cell therapy services

Pharmaceuticals and medical preparations for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; chemical preparations for pharmaceutical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; drugs for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; immunostimulants; medicines for human purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceutical preparations, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; Pharmaceutical compositions for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical use, Living cells for medical use; vaccine preparation; Medical diagnostic preparations

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 6, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 6, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 6, 2026 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 17, 2024 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 25, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 25, 2023 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 20, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 20, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 17, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2022 NWOS
NEW APPLICATION ENTERED
Jun 10, 2022 NWAP